Literature DB >> 7127896

Impairment of graft versus host reactivity in pregnant mice.

S Nicklin, W D Billington.   

Abstract

The popliteal lymph node (PLN) assay for graft versus host (GVH) reactivity has been used to analyse specific features associated with the immunological aspects of the materno-fetal relationship. GVH responses induced following the injection of maternal lymphocytes into F1 hybrid recipients is a particularly relevant model for testing the cellular reactivity of maternal lymphocytes against F1 hybrid determinants since every allogeneic pregnancy could initiate a naturally occurring mother versus F1 allograft reaction. Experiments monitored sequentially the effects of the pregnancy environment and multiparity on maternal cell-mediated immunity. The PLN assay performed within the confines of pregnant F1 hosts indicated that GVH reactivity was significantly suppressed during the mid and late stages of gestation with suppression being greatest in allogeneic combinations. In addition cells obtained from pregnant donors were less efficient than normal cells at GVH induction when transferred to virgin F1 recipients. The suppressive effect was maximal at mid-gestation; however, in this situation, the genotype of the paternal strain had no significant effect on the degree of immunosuppression observed. Multiparity in allogeneic combinations induced anti-paternal humoral immunity but an equivalent increase in GVH reactivity was not detected. These results support the concept of pregnancy-associated suppression of cell-mediated immunity. The nature of the suppressive effect is discussed.

Entities:  

Mesh:

Year:  1982        PMID: 7127896      PMCID: PMC1536638     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Antigenicity of trophoblast and possible antigen-masking effects during pregnancy.

Authors:  P V Taylor; K W Hancock
Journal:  Immunology       Date:  1975-05       Impact factor: 7.397

2.  Suppression of maternal responsiveness to paternal antigen by maternal plasma.

Authors:  H Pence; W M Petty; R E Rocklin
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

3.  Depression of cellular immune response during syngeneic pregnancy as measured by the graft-versus-host reaction.

Authors:  G Parmiani; G Invernizzi
Journal:  Transplantation       Date:  1975-05       Impact factor: 4.939

4.  Non-specific decrease of cell-mediated immunity in female mice during syngeneic and allogeneic pregnancy.

Authors:  A Skowron-Cendrzak; W Ptak; M Bubak; Z Czarnik
Journal:  Folia Biol (Praha)       Date:  1975       Impact factor: 0.906

5.  The host component of the graft-versus-host reaction. A study on the popliteal lymph node reaction in the rat.

Authors:  B Rolstad
Journal:  Transplantation       Date:  1976-02       Impact factor: 4.939

6.  Studies on autochthonous antigenic nature of human trophoblasts by mixed-leucocyte trophoblast-culture (MLTC) in vitro.

Authors:  K Kanazawa
Journal:  Acta Obstet Gynaecol Jpn       Date:  1974-01

7.  Leukocyte antibodies: occurrence in primigravidae.

Authors:  S Ahrons
Journal:  Tissue Antigens       Date:  1971

8.  Progressive increase in cell-mediated immunity against paternal transplantation antigens in parous mice after multiple pregnancies.

Authors:  E S Maroni; D M Parrott
Journal:  Clin Exp Immunol       Date:  1973-02       Impact factor: 4.330

9.  Maternal immunization to paternal antigens in multiparous mice.

Authors:  M G Baines; J Ansell; A McLaren; H S Micklem
Journal:  J Reprod Fertil       Date:  1975-02

10.  The blocking by autologous serum of maternal cell-mediated immune reactions to placental antigen.

Authors:  A R Rabson; M C Bey; J E Kerrich; H J Koornhof
Journal:  S Afr Med J       Date:  1976-02-14
View more
  1 in total

1.  Pregnancy alters the proliferation and apoptosis of mouse splenic erythroid lineage cells and leukocytes.

Authors:  Michelle T Norton; Karen A Fortner; Peyman Bizargity; Elizabeth A Bonney
Journal:  Biol Reprod       Date:  2009-04-15       Impact factor: 4.285

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.